Page Industries Ltd
₹35750
+470 (1.33%)
Fri, 06 Nov 2026, 09:36 pm
Page Industries News
Page Industries files appeal in Dubai litigation
Page Industries has filed an appeal regarding jurisdiction after a Dubai court dismissed Yellow Flower Trading's claim. YFT also appealed the dismissal.
26 Oct 2026
companies
Dubai court dismisses claim against Page Industries
The Dubai Court has dismissed a claim by Yellow Flower Trading LLC against Page Industries due to non-payment of an expert deposit. The plaintiff must bear court fees and costs.
21 Sept 2026
companies
Page Industries: ₹34.40cr Block Trade on BSE
Page Industries saw a block trade of ~8,516 shares on BSE at ₹40,400.00 per share, amounting to a total transaction value of ₹34.40 crore.
24 Jul 2026
equity-markets
Page Industries FY26 BRSR report
Page Industries reported revenues of ₹5,246.8 crore in FY 2025-26, achieving significant reductions in energy and water intensity while maintaining 100% WRAP certification across all manufacturing units.
19 Jul 2026
companies
Page Industries sets 31st AGM date
Page Industries announced its 31st AGM on August 13, 2026, via video conferencing. E-voting runs from August 10 to 12.
17 Jul 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo